会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • HEPATITIS-C VIRUS 4, 5 AND 6
    • HEPATITIS-C VIRUS 4,5和6
    • US20070160630A1
    • 2007-07-12
    • US11676842
    • 2007-02-20
    • Peter SimmondsPeng YapIan Pike
    • Peter SimmondsPeng YapIan Pike
    • C12Q1/68A61K39/12
    • C07K14/005A61K39/00A61K39/12A61K39/29C12N2770/24222C12N2770/24234C12Q1/706C12Q1/707G01N33/56983G01N2333/18G01N2469/20Y10S436/811Y10S436/82Y10S436/825Y10S530/806Y10S530/811Y10S530/826
    • The present invention relates to a polynucleic acid composition comprising or consisting of at least one polynucleic acid containing 8 or more contiguous nucleotides corresponding to a nucleotide sequence from the region spanning positions 417 to 957 of the Core/E1 region of HCV type 3; and/or the region spanning positions 4664 to 4730 of the NS3 region of HCV type 3; and/or the region spanning positions 4892 to 5292 of the NS3/4 region of HCV type 3; and/or the region spanning positions 8023 to 8235 of the NS5 region of the BR36 subgroup of HCV type 3a; and/or the coding region of HCV type 4a starting at nucleotide 379 in the core region; and/or the coding region of HCV type 4; and/or the coding region of HCV type 5, with said nucleotide numbering being with respect to the numbering of HCV nucleic acids as shown in Table 1, and with said polynucleic acids containing at least one nucleotide difference with known HCV type 1, and/or HCV type 2 genomes in the above-indicated regions, or the complement thereof.
    • 本发明涉及包含至少一种含有8个或更多个连续核苷酸的多核苷酸的多核酸组合物,其对应于来自HCV 3型核心/ E1区域的位置417至957的区域的核苷酸序列; 和/或跨越HCV 3型NS3区域的位置4664至4730的区域; 和/或跨越HCV 3型NS3 / 4区的位置4892至5292的区域; 和/或跨越HCV3型BR36亚组的NS5区域的位置8023至8235的区域; 和/或从核心区域的核苷酸379开始的HCV型4a的编码区; 和/或HCV 4型的编码区; 和/或HCV 5型的编码区,其中所述核苷酸编号相对于表1所示的HCV核酸的编号,并且所述多核苷酸与已知的HCV I型具有至少一个核苷酸差异,和/ 或HCV 2型基因组,或其补体。
    • 8. 发明授权
    • Hepatitis-C virus type 4, 5 and 6
    • 丙型肝炎病毒4型,5型和6型
    • US07728121B2
    • 2010-06-01
    • US11933672
    • 2007-11-01
    • Peter SimmondsPeng Lee YapIan Hugo Pike
    • Peter SimmondsPeng Lee YapIan Hugo Pike
    • C07H21/00A61K39/38A61K39/29
    • C07K14/005A61K39/00A61K39/12A61K39/29C12N2770/24222C12N2770/24234C12Q1/706C12Q1/707G01N33/56983G01N2333/18G01N2469/20Y10S436/811Y10S436/82Y10S436/825Y10S530/806Y10S530/811Y10S530/826
    • The present invention relates to a polynucleic acid composition comprising or consisting of at least one polynucleic acid containing 8 or more contiguous nucleotides corresponding to a nucleotide sequence from the region spanning positions 417 to 957 of the Core/E1 region of HCV type 3; and/or the region spanning positions 4664 to 4730 of the NS3 region of HCV type 3; and/or the region spanning positions 4892 to 5292 of the NS3/4 region of HCV type 3; and/or the region spanning positions 8023 to 8235 of the NS5 region of the BR36 subgroup of HCV type 3a; and/or the coding region of HCV type 4a starting at nucleotide 379 in the core region; and/or the coding region of HCV type 4; and/or the coding region of HCV type 5, with said nucleotide numbering being with respect to the numbering of HCV nucleic acids as shown in Table 1, and with said polynucleic acids containing at least one nucleotide difference with known HCV type 1, and/or HCV type 2 genomes in the above-indicated regions, or the complement thereof.
    • 本发明涉及包含至少一种含有8个或更多个连续核苷酸的多核苷酸的多核酸组合物,其对应于来自HCV 3型核心/ E1区域的位置417至957的区域的核苷酸序列; 和/或跨越HCV 3型NS3区域的位置4664至4730的区域; 和/或跨越HCV 3型NS3 / 4区的位置4892至5292的区域; 和/或跨越HCV3型BR36亚组的NS5区域的位置8023至8235的区域; 和/或从核心区域的核苷酸379开始的HCV型4a的编码区; 和/或HCV 4型的编码区; 和/或HCV 5型的编码区,其中所述核苷酸编号相对于表1所示的HCV核酸的编号,并且所述多核苷酸与已知的HCV I型具有至少一个核苷酸差异,和/ 或上述区域中的HCV 2型HCV基因组,或其补体。